PubMed

Potential population impact of the UK government strategy for reducing the burden of coronary heart disease in England: comparing primary and secondary prevention strategies.

Gemmell I, Heller RF, Payne K, Edwards R, Roland M, Durrington P.

Qual Saf Health Care. 2006 Oct;15(5):339-43.PMID: 17074870 [PubMed - indexed for MEDLINE]Related articlesFree article

Population impact of stricter adherence to recommendations for pharmacological and lifestyle interventions over one year in patients with coronary heart disease.

Gemmell I, Heller RF, McElduff P, Payne K, Butler G, Edwards R, Roland M, Durrington P.

J Epidemiol Community Health. 2005 Dec;59(12):1041-6.PMID: 16286491 [PubMed - indexed for MEDLINE]Related articlesFree article

Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention.

Unal B, Critchley JA, Capewell S.

BMJ. 2005 Sep 17;331(7517):614. Epub 2005 Aug 17.PMID: 16107431 [PubMed - indexed for MEDLINE]Related articlesFree article

Implications of small reductions in diastolic blood pressure for primary prevention.

Cook NR, Cohen J, Hebert PR, Taylor JO, Hennekens CH.

Arch Intern Med. 1995 Apr 10;155(7):701-9.PMID: 7695458 [PubMed - indexed for MEDLINE]Related articles

A systematic review and economic evaluation of statins for the prevention of coronary events.

Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.PMID: 17408535 [PubMed - indexed for MEDLINE]Related articlesFree article

Will changes in primary care improve health outcomes? Modelling the impact of financial incentives introduced to improve quality of care in the UK.

McElduff P, Lyratzopoulos G, Edwards R, Heller RF, Shekelle P, Roland M.

Qual Saf Health Care. 2004 Jun;13(3):191-7.PMID: 15175489 [PubMed - indexed for MEDLINE]Related articlesFree article

Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.

Whitfield MD, Gillett M, Holmes M, Ogden E.

Public Health. 2006 Dec;120(12):1140-8. Epub 2006 Nov 3.PMID: 17084425 [PubMed - indexed for MEDLINE]Related articles

Population implications of lipid lowering for prevention of coronary heart disease: data from the 1995 Scottish health survey.

Haq IU, Ramsay LE, Wallis EJ, Isles CG, Ritchie LD, Jackson PR.

Heart. 2001 Sep;86(3):289-95.PMID: 11514481 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000.

Kabir Z, Bennett K, Shelley E, Unal B, Critchley JA, Capewell S.

BMC Public Health. 2007 Jun 21;7:117.PMID: 17584932 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevalence and management of coronary heart disease in primary care: population-based cross-sectional study using a disease register.

Carroll K, Majeed A, Firth C, Gray J.

J Public Health Med. 2003 Mar;25(1):29-35.PMID: 12669915 [PubMed - indexed for MEDLINE]Related articlesFree article

Lipid-lowering for prevention of coronary heart disease: what policy now?

Ul Haq I, Ramsay LE, Pickin DM, Yeo WW, Jackson PR, Payne JN.

Clin Sci (Lond). 1996 Oct;91(4):399-413. Erratum in: Clin Sci (Colch) 1996 Dec;91(6):773-4. PMID: 8983865 [PubMed - indexed for MEDLINE]Related articles

Guideline implementation in a multicenter study with an estimated 44% relative cardiovascular event risk reduction.

Onat A, Soydan I, Tokgözoğlu L, Sansoy V, Koylan N, Domaniç N, Ural D; Riskburden Study Group, Turkish Society of Cardiology.

Clin Cardiol. 2003 May;26(5):243-9.PMID: 12769254 [PubMed - indexed for MEDLINE]Related articles

Meeting the National Service Framework for coronary heart disease: which patients have untreated high blood pressure?

Marshall T, Rouse A.

Br J Gen Pract. 2001 Jul;51(468):571-4.PMID: 11462320 [PubMed - indexed for MEDLINE]Related articlesFree article

The causes and effects of socio-demographic exclusions from clinical trials.

Bartlett C, Doyal L, Ebrahim S, Davey P, Bachmann M, Egger M, Dieppe P.

Health Technol Assess. 2005 Oct;9(38):iii-iv, ix-x, 1-152. Review.PMID: 16181564 [PubMed - indexed for MEDLINE]Related articlesFree article

Pravastatin. A pharmacoeconomic review of its use in primary and secondary prevention of coronary heart disease.

Coukell AJ, Wilde MI.

Pharmacoeconomics. 1998 Aug;14(2):217-36. Review.PMID: 10186462 [PubMed - indexed for MEDLINE]Related articles

The prevalence of cardiovascular disease risk factors in patients from Croatian Zagorje County treated at Department of Medicine, Zabok General Hospital from 2000 to 2006.

Pesek K, Pesek T, Rados M, Buković D, Fures R, Cuk V.

Coll Antropol. 2007 Sep;31(3):709-15.PMID: 18041378 [PubMed - indexed for MEDLINE]Related articles

Opportunities for control of coronary heart disease in Australia.

McElduff P, Dobson AJ, Jamrozik K, Hobbs MS.

Aust N Z J Public Health. 2001;25(1):24-30.PMID: 11297296 [PubMed - indexed for MEDLINE]Related articles

Targeted versus global approaches to the management of hypercholesterolaemia.

Reynolds TM, Mardani A, Twomey PJ, Wierzbickid AS.

J R Soc Promot Health. 2008 Sep;128(5):248-54.PMID: 18814407 [PubMed - indexed for MEDLINE]Related articles

Should we encourage over-the-counter statins? A population perspective for coronary heart disease prevention.

Gemmell I, Verma A, Harrison RA.

Am J Cardiovasc Drugs. 2007;7(4):299-302.PMID: 17696570 [PubMed - indexed for MEDLINE]Related articles

Coronary heart disease and cardiovascular risk factors among people aged 25-65 years, as seen in Romanian primary healthcare.

Bunescu DM, Stoffers HE, van den Akker M, Jan Dinant G.

Eur J Gen Pract. 2008;14(2):56-64.PMID: 18720274 [PubMed - indexed for MEDLINE]Related articles